Evaluation of Corneal Aberrometry Parameters Before and After Cross-Linking in Patients with Keratoconus
Authors
Abstract:
Background and Objective: In the last decade, cross-linking (CXL) has been widely used for treating people with progressive keratoconus. The present study aimed to compare corneal aberrometry parameters before and after CXL in patients with keratoconus. Materials and Methods: In this cross-sectional study, 67 patients with keratoconus referred to Farshchian Sina Medical Education Center, Hamadan, Iran, who underwent CXL surgery at Mahdia Surgery Center, were selected. The results of refractometry and aberrometry before the surgery and six months after the CXL, were examined and compared. Data were extracted from patients’ medical records and analyzed in SPSS software (version 26). A P-valuec less than 0.05 was considered statistically significant. Results: The mean age of patients was 22.28 ± 5.03 years, and 65.7% were male. Mean aberrometry parameters before and six months after the treatment for K1: 44.33 and 44.04 (P=0.003), K2: 48.01 and 47.91 (P<0.001), Km: 46.27, and 45.86 (P<0.001), Kmax: 51.72 and 51.34 (P<0.001), astigmatism: 3.59 and 3.93 (P<0.001), Thanet Local: 472.76 and 462.37 (P<0.001) and CDVA: 6.41 and 8.25 (P<0.001). No significant difference was oberved between CCT, Rms Total, Rms LDA, Coma, and sphere parameters before and after the CXl. Conclusion: Cross-linking is an effective method for treating keratoconus in adults, leading to the correction of most corneal aberrometry parameters, including K1, K2, Km, Kmax, astigmatism, thinnest location, and CDVA within six months.
similar resources
topographic corneal changes after collagen cross-linking in patients with corneal keratoconus
background: corneal collagen cross-linking with riboflavin, also known as collagen cross-linking (cxl), involves the application of riboflavin solution to the eye that is activated by illumination with ultraviolet a (uva) light. we survey here the topographic corneal changes one year after cxl in patients with corneal keratoconus. materials and methods: this prospective randomized clinical tria...
full textlens densitometry changes after corneal collagen cross-linking in patients with keratoconus using pentacam scheimpflug camera
purpose: to evaluate densitometry of crystalline lens after cxl procedure in keratoconic patients. methods: in a quasi-experimental study three-dimensional lens densitometry was performed by pentacam scheimpflug camera at base line and 6 months later. subject group contained patients with diagnosed progressive keratoconus who underwent cxl surgery (n = 40). control group contained aged-matched ...
full textTopographic corneal changes after collagen cross-linking in patients with corneal keratoconus
BACKGROUND Corneal collagen cross-linking with riboflavin, also known as collagen cross-linking (CXL), involves the application of riboflavin solution to the eye that is activated by illumination with ultraviolet A (UVA) light. We survey here the topographic corneal changes one year after CXL in patients with corneal keratoconus. MATERIALS AND METHODS This prospective randomized clinical tria...
full textCorneal cross linking for keratoconus.
Riboflavin-induced ultraviolet light (UV) cross linking has received a significant amount of attention in recent years. It is currently approved in Europe as a treatment for keratoconus and is also being used for other corneal disorders. The goal of this paper is to review in detail seminal papers and studies that have been done to support cross linking as a safe and effective treatment for pat...
full textDifferences in corneal clinical findings after standard and accelerated cross-linking in patients with progressive keratoconus
BACKGROUND The purpose of this study was to identify differences in clinical corneal findings after standard and accelerated epithelial off cross-linking (CXL) during a long-term follow-up. METHODS Two hundred forty-one patients (184 male) were included in this monocentric, retrospective, non-randomized and unmasked study. One hundred forty-eight eyes were treated with the accelerated protoco...
full textMy Resources
Journal title
volume 29 issue 4
pages 225- 231
publication date 2023-03
By following a journal you will be notified via email when a new issue of this journal is published.
No Keywords
Hosted on Doprax cloud platform doprax.com
copyright © 2015-2023